Dr. Roy Jensen

Dr. Roy Jensen, MD, is a nationally recognized pathologist and cancer researcher specializing in breast cancer biology and molecular oncology. He serves as Director of The University of Kansas Cancer Center, where he has overseen the institution’s achievement of NCI Comprehensive Cancer Center designation. Dr. Jensen earned his medical degree, completed residency training in pathology, and pursued fellowship training in oncologic pathology. He is board-certified in Pathology and widely acknowledged for his leadership in advancing cancer research and institutional development.

Dr. Jensen’s research has focused on the molecular mechanisms underlying breast cancer progression and the development of targeted therapies. He has authored extensively in leading journals, contributed to national and international research collaborations, and played a central role in advancing precision medicine approaches for breast cancer. His leadership has helped shape the growth of translational research programs and fostered the integration of laboratory discoveries into clinical practice.

In addition to his research and leadership, Dr. Jensen is a committed educator and mentor, training pathologists, oncologists, and researchers. He has served in leadership roles within the National Cancer Institute and professional societies and has been recognized for his contributions to advancing cancer policy and standards. Through his commitment to research, education, and institutional leadership, Dr. Roy Jensen continues to influence cancer care and research on a national level.